Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$3.37 - $6.86 $1.76 Million - $3.58 Million
-522,002 Reduced 18.38%
2,318,050 $15 Billion
Q3 2023

Nov 14, 2023

BUY
$4.7 - $8.55 $4.69 Million - $8.53 Million
997,700 Added 54.15%
2,840,052 $14.3 Billion
Q2 2023

Aug 14, 2023

SELL
$7.35 - $13.29 $1.14 Million - $2.06 Million
-154,703 Reduced 7.75%
1,842,352 $16.1 Billion
Q1 2023

May 15, 2023

BUY
$7.91 - $12.0 $15.8 Million - $24 Million
1,997,055 New
1,997,055 $23.6 Billion

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $218M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Braidwell LP Portfolio

Follow Braidwell LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

News

Stay updated on Braidwell LP with notifications on news.